These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 28676069)

  • 1. Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature.
    Derrett-Smith EC; Martyanov V; Chighizola CB; Moinzadeh P; Campochiaro C; Khan K; Wood TA; Meroni PL; Abraham DJ; Ong VH; Lafyatis R; Whitfield ML; Denton CP
    Arthritis Res Ther; 2017 Jul; 19(1):156. PubMed ID: 28676069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular subsets in the gene expression signatures of scleroderma skin.
    Milano A; Pendergrass SA; Sargent JL; George LK; McCalmont TH; Connolly MK; Whitfield ML
    PLoS One; 2008 Jul; 3(7):e2696. PubMed ID: 18648520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compendium of skin molecular signatures identifies key pathological features associated with fibrosis in systemic sclerosis.
    Moon SJ; Bae JM; Park KS; Tagkopoulos I; Kim KJ
    Ann Rheum Dis; 2019 Jun; 78(6):817-825. PubMed ID: 30952646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Egr-1 induces a profibrotic injury/repair gene program associated with systemic sclerosis.
    Bhattacharyya S; Sargent JL; Du P; Lin S; Tourtellotte WG; Takehara K; Whitfield ML; Varga J
    PLoS One; 2011; 6(9):e23082. PubMed ID: 21931594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.
    McCoy SS; Reed TJ; Berthier CC; Tsou PS; Liu J; Gudjonsson JE; Khanna D; Kahlenberg JM
    Rheumatology (Oxford); 2017 Nov; 56(11):1970-1981. PubMed ID: 28968684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial Response to Type I Interferon Contributes to Vasculopathy and Fibrosis and Predicts Disease Progression of Systemic Sclerosis.
    Yin H; Distler O; Shen L; Xu X; Yuan Y; Li R; Liu B; Li Q; Huang Q; Xie F; Zhang Z; Liang R; Dai X; Chen X; Li B; Yan Q; Lu L
    Arthritis Rheumatol; 2024 Jan; 76(1):78-91. PubMed ID: 37488975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
    Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N;
    J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HLA-B*35 allele modulates ER stress, inflammation and proliferation in PBMCs from Limited Cutaneous Systemic Sclerosis patients.
    Lenna S; Assassi S; Farina GA; Mantero JC; Scorza R; Lafyatis R; Farber HW; Trojanowska M
    Arthritis Res Ther; 2015 Dec; 17():363. PubMed ID: 26669670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis.
    Taroni JN; Greene CS; Martyanov V; Wood TA; Christmann RB; Farber HW; Lafyatis RA; Denton CP; Hinchcliff ME; Pioli PA; Mahoney JM; Whitfield ML
    Genome Med; 2017 Mar; 9(1):27. PubMed ID: 28330499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon.
    Higley H; Persichitte K; Chu S; Waegell W; Vancheeswaran R; Black C
    Arthritis Rheum; 1994 Feb; 37(2):278-88. PubMed ID: 7510487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.
    Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ;
    Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key genes and immune profile in limited cutaneous systemic sclerosis-associated pulmonary arterial hypertension by bioinformatics analysis.
    Zhang T; Huang C; Luo H; Li J; Huang H; Liu X; Zhan S
    Life Sci; 2021 Apr; 271():119151. PubMed ID: 33539912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis.
    Nihtyanova SI; Sari A; Harvey JC; Leslie A; Derrett-Smith EC; Fonseca C; Ong VH; Denton CP
    Arthritis Rheumatol; 2020 Mar; 72(3):465-476. PubMed ID: 31682743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis.
    Brkic Z; van Bon L; Cossu M; van Helden-Meeuwsen CG; Vonk MC; Knaapen H; van den Berg W; Dalm VA; Van Daele PL; Severino A; Maria NI; Guillen S; Dik WA; Beretta L; Versnel MA; Radstake T
    Ann Rheum Dis; 2016 Aug; 75(8):1567-73. PubMed ID: 26371289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression of RXFP1 receptor contributes to the inefficacy of relaxin-based anti-fibrotic treatments in systemic sclerosis.
    Corallo C; Pinto AM; Renieri A; Cheleschi S; Fioravanti A; Cutolo M; Soldano S; Nuti R; Giordano N
    Clin Exp Rheumatol; 2019; 37 Suppl 119(4):69-75. PubMed ID: 31365333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of NLRP3 inflammasome, cytokines and vascular mediators in the skin of systemic sclerosis patients.
    Martínez-Godínez MA; Cruz-Domínguez MP; Jara LJ; Domínguez-López A; Jarillo-Luna RA; Vera-Lastra O; Montes-Cortes DH; Campos-Rodríguez R; López-Sánchez DM; Mejía-Barradas CM; Castelán-Chávez EE; Miliar-García A
    Isr Med Assoc J; 2015 Jan; 17(1):5-10. PubMed ID: 25739168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplex cytokine analysis of dermal interstitial blister fluid defines local disease mechanisms in systemic sclerosis.
    Clark KE; Lopez H; Abdi BA; Guerra SG; Shiwen X; Khan K; Etomi O; Martin GR; Abraham DJ; Denton CP; Stratton RJ
    Arthritis Res Ther; 2015 Mar; 17(1):73. PubMed ID: 25885360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin.
    Mathes AL; Christmann RB; Stifano G; Affandi AJ; Radstake TR; Farina GA; Padilla C; McLaughlin S; Lafyatis R
    Ann Rheum Dis; 2014 Oct; 73(10):1864-72. PubMed ID: 23873879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systems level analysis of systemic sclerosis shows a network of immune and profibrotic pathways connected with genetic polymorphisms.
    Mahoney JM; Taroni J; Martyanov V; Wood TA; Greene CS; Pioli PA; Hinchcliff ME; Whitfield ML
    PLoS Comput Biol; 2015 Jan; 11(1):e1004005. PubMed ID: 25569146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.